Table 3.
Gender- and Race-Stratified Prevalence of Various Metabolic Syndrome Definitions
| |
|
|
Males |
|
Females |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Definitions | All | All males | Caucasians | Chinese | African American | Hispanics | All females | Caucasians | Chinese | African American | Hispanics |
| NCEP | 33.10% | 29.23% | 28.67% | 18.86% | 29.34% | 35.64% | 36.56% | 31.36% | 31.31% | 36.72% | 48.25% |
| AHA | 37.82% | 33.87% | 31.79% | 33.85% | 34.85% | 38.97% | 40.43% | 33.88% | 41.99% | 41.47% | 51.49% |
| WHO | 31.58% | 34.13% | 27.43% | 30.75% | 37.96% | 43.13% | 29.30% | 19.73% | 26.39% | 36.46% | 38.03% |
| EGIR | 24.52% | 23.21% | 22.65% | 16.28% | 27.90% | 33.98% | 22.08% | 15.52% | 16.95% | 30.27% | 31.31% |
| IDF | 41.22% | 39.58% | 37.11% | 25.84% | 39.52% | 51.32% | 42.68% | 35.77% | 39.47% | 44.29% | 54.33% |
| Con-IDF | 42.54% | 42.04% | 38.04% | 33.59% | 42.16% | 53.40% | 42.99% | 35.99% | 41.89% | 44.39% | 53.95% |
| Con-AHA | 40.89% | 39.51% | 31.58% | 33.59% | 42.16% | 53.40% | 42.12% | 33.70% | 41.89% | 44.39% | 53.95% |
NCEP, National Cholesterol Education Program; AHA, American Heart Association; WHO, World Health Organization, IDF, International Diabetes Federation; EGIR, European Group for the Study of Insulin Resistance; Con, consensus.